Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.nature.com › articles › s43018/021/00192-xAdvancing Cancer Therapy - Nature

   www.nature.com › articles › s43018/021/00192-x

   24 mar 2021 · In this issue, we launch our Series on Cancer Therapy, exploring current paradigms and recent advances and challenges in this field, through specially commissioned articles.

   • Metrics

     Metrics - Advancing Cancer Therapy - Nature

   • Editorials

     Deeper insights into context-specific cancer cell states and...

   • RSS Feed

     Nature Cancer aims to publish the most significant advances...

   • Editorial Policies

     The Nature Portfolio journals' editorial policies for...

   • Submit Manuscript

     Submit Manuscript - Advancing Cancer Therapy - Nature

   • Current Issue

     Dong et al. demonstrate that targeting arginine...

2. www.nature.com › articles › s41392/024/01856-7Exploring treatment options in cancer: tumor treatment strategies...

   www.nature.com › articles › s41392/024/01856-7

   17 lip 2024 · In this review, we discussed the different treatment modalities, including small molecule targeted drugs, peptide drugs, antibody drugs, cell therapy, and gene therapy.

3. www.nejm.org › doi › fullInavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer

   www.nejm.org › doi › full

   3 dni temu · 2m 23s. Activating mutations in PIK3CA occur in approximately 35 to 40% of hormone receptor–positive breast cancers. 1-4 The presence of such mutations is a poor prognostic factor in patients ...

4. cancer.osu.edu › radiation-oncology › treatmentProton Therapy: Advanced Cancer Treatment | OSUCCC – James

   cancer.osu.edu › radiation-oncology › treatment

   • Zapisane w pamięci cache

   An advanced cancer treatment, proton therapy precisely targets tumor cells while preserving nearby healthy cells. The new Proton Therapy Center offers comprehensive radiation oncology treatment options for both adult and pediatric patients and is located within The James Outpatient Care Clinic.

5. aacrjournals.org › clincancerres › articleTargeted Therapies, Novel Antibodies, and Immunotherapies in...

   aacrjournals.org › clincancerres › article

   • Zapisane w pamięci cache

   1 dzień temu · Non–small cell lung cancer (NSCLC) is one of the leading causes for cancer-related mortality worldwide, with an estimated annual global death toll of more than 1.5 million ().For advanced NSCLC, systemic treatment is the standard therapeutic modality (2, 3).For approximately 30 years, platinum-based chemotherapy constituted the backbone of anticancer therapy (), yet response rates have ...

6. pubmed.ncbi.nlm.nih.gov › 36166727Combination Dabrafenib and Trametinib Versus Combination...

   pubmed.ncbi.nlm.nih.gov › 36166727

   10 sty 2023 · Purpose: Combination programmed cell death protein 1/cytotoxic T-cell lymphocyte-4-blockade and dual BRAF/MEK inhibition have each shown significant clinical benefit in patients with BRAFV600 -mutant metastatic melanoma, leading to broad regulatory approval.

7. health.osu.edu › discovery-and-innovation › treatment-advancesFLASH proton therapy FAQ | Ohio State Health & Discovery

   health.osu.edu › discovery-and-innovation › treatment-advances

   • Zapisane w pamięci cache

   6 kwi 2023 · FLASH proton therapy is an experimental form of proton therapy that delivers treatment literally in a flash. FLASH delivers an ultra-high dose rate of radiation in less than one second. A cancer treatment that leaves less damage behind: proton therapy’s big promise.